212-681-1575
May

25

Good News, Bad News With Immunotherapy Care for Me...

Posted by

Label: Mesothelioma


With immunotherapy being a new, and sometimes experimental, treatment for mesothelioma patients, the benefits are still being uncovered. However, so too are the side effects and drawbacks. This month’s news has brought updates on both the pros and cons of

Read Full Story

Want Specific topic updates?


Immunotheraphy GE Healthcare Life Sciences

In December, MesotheliomaHelp reported that Roche’s immunotherapy drug atezolizumab (now known as TECENTRIQ), saw positive results in two Phase II clinical trials for non-small cell lung cancer patients (NSCLC). Now, Roche reports, in a separate trial the drug helped some

Read Full Story

Want Specific topic updates?